Effects of actinomycin and puromycin on the cytochemical-staining characteristics of vaccinia-infected cells.
D000135:Acid Phosphatase / Q000378:metabolism; D002467:Cell Nucleus; D046508:Culture Techniques; D004247:DNA / Q000378:metabolism; D003609:Dactinomycin / Q000494:pharmacology*; D006651:Histocytochemistry; D006801:Humans; D008247:Lysosomes; D008854:Microscopy, Electron; D008856:Microscopy, Fluorescence; D008928:Mitochondria; D011691:Puromycin / Q000494:pharmacology*; D012313:RNA / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D013194:Staining and Labeling; D014616:Vaccinia virus / Q000187:drug effects*
D012333:RNA, Messenger; D003609:Dactinomycin; D011691:Puromycin; D012313:RNA; D004247:DNA; D000135:Acid Phosphatase